dc.contributor.author | Petralia, G | |
dc.contributor.author | Koh, D-M | |
dc.contributor.author | Attariwala, R | |
dc.contributor.author | Busch, JJ | |
dc.contributor.author | Eeles, R | |
dc.contributor.author | Karow, D | |
dc.contributor.author | Lo, GG | |
dc.contributor.author | Messiou, C | |
dc.contributor.author | Sala, E | |
dc.contributor.author | Vargas, HA | |
dc.contributor.author | Zugni, F | |
dc.contributor.author | Padhani, AR | |
dc.date.accessioned | 2021-08-12T10:06:40Z | |
dc.date.available | 2021-08-12T10:06:40Z | |
dc.date.issued | 2021-06-01 | |
dc.identifier.citation | Radiology, 2021, 299 (3), pp. 494 - 507 | |
dc.identifier.issn | 0033-8419 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4747 | |
dc.identifier.eissn | 1527-1315 | |
dc.identifier.doi | 10.1148/radiol.2021201740 | |
dc.description.abstract | Acknowledging the increasing number of studies describing the use of whole-body MRI for cancer screening, and the increasing number of examinations being performed in patients with known cancers, an international multidisciplinary expert panel of radiologists and a geneticist with subject-specific expertise formulated technical acquisition standards, interpretation criteria, and limitations of whole-body MRI for cancer screening in individuals at higher risk, including those with cancer predisposition syndromes. The Oncologically Relevant Findings Reporting and Data System (ONCO-RADS) proposes a standard protocol for individuals at higher risk, including those with cancer predisposition syndromes. ONCO-RADS emphasizes structured reporting and five assessment categories for the classification of whole-body MRI findings. The ONCO-RADS guidelines are designed to promote standardization and limit variations in the acquisition, interpretation, and reporting of whole-body MRI scans for cancer screening. Published under a CC BY 4.0 license Online supplemental material is available for this article. | |
dc.format | Print-Electronic | |
dc.format.extent | 494 - 507 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | RADIOLOGICAL SOC NORTH AMERICA (RSNA) | |
dc.title | Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening. | |
dc.type | Journal Article | |
rioxxterms.versionofrecord | 10.1148/radiol.2021201740 | |
rioxxterms.licenseref.startdate | 2021-06 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Radiology | |
pubs.issue | 3 | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics | |
pubs.organisational-group | /ICR/Primary Group/Royal Marsden Clinical Units | |
pubs.publication-status | Published | |
pubs.volume | 299 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Oncogenetics | |
icr.researchteam | Oncogenetics | |
dc.contributor.icrauthor | Eeles, Rosalind | |